Application 021539

Type
NDA
Sponsor
CUMBERLAND PHARMS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001ACETADOTEACETYLCYSTEINEINJECTABLE;INTRAVENOUS6GM/30ML (200MG/ML)YesYes

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
0574-0805acetylcysteineAcetylcysteinePaddock Laboratories, LLCNDACurrent
0574-0805acetylcysteineAcetylcysteinePadagis US LLCNDACurrent
0574-0805acetylcysteineAcetylcysteinePaddock Laboratories, LLCNDACurrent
0574-0805acetylcysteineAcetylcysteinePaddock Laboratories, LLC.NDACurrent
0574-0815AcetylcysteineacetylcysteinePaddock Laboratories, LLCNDACurrent
0574-0815AcetylcysteineacetylcysteinePaddock Laboratories, LLCNDACurrent
0574-0815AcetylcysteineacetylcysteinePaddock Laboratories, LLCNDACurrent
66220-207ACETADOTEAcetylcysteineCumberland PharmaceuticalNDACurrent
66220-207ACETADOTEAcetylcysteineCumberland Pharmaceuticals Inc.NDACurrent
66220-207ACETADOTEAcetylcysteineCumberland Pharmaceuticals Inc.NDACurrent
66220-207ACETADOTEAcetylcysteineCumberland Pharmaceuticals Inc.NDACurrent
66220-207ACETADOTEAcetylcysteineCumberland Pharmaceuticals Inc.NDACurrent
66220-207ACETADOTEAcetylcysteineCumberland Pharmaceuticals Inc.NDACurrent

Documents

DocumentSubmission typeDate
82934SUPPL 2025-07-25
82918SUPPL 2025-07-25
80442SUPPL 2024-11-29
80436SUPPL 2024-11-27
68797SUPPL2021-09-28
60762SUPPL2019-10-31
60749SUPPL2019-10-31
46987SUPPL2017-01-27
46959SUPPL2017-01-24
37182SUPPL2016-08-02
5682SUPPL2016-08-02
15726SUPPL2013-06-11
28061SUPPL2013-06-06
5681SUPPL2008-12-19
37181SUPPL2006-02-22
5680SUPPL2006-02-22
42205ORIG2004-10-18
37180SUPPL2004-05-04
15725SUPPL2004-05-04
28060SUPPL2004-05-03
28059SUPPL2004-04-29
15724ORIG2004-02-03
5679ORIG2004-02-02